User profiles for KENICHI MATSUO

Matsuo Kenichi

Showa University Fujigaoka Hospital
Verified email at med.showa-u.ac.jp
Cited by 4011

Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases

K Tanaka, H Shimada, K Matsuo, Y Nagano, I Endo… - Surgery, 2004 - Elsevier
BACKGROUND: Consensus has not been reached concerning the timing of hepatectomy in
patients with synchronous colorectal liver metastases, specifically with respect to patient …

The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients

K Matsuo, FG Rocha, K Ito, MI D'Angelica… - Journal of the American …, 2012 - Elsevier
BACKGROUND: Complete resection of hilar cholangiocarcinoma (HCCA) is a critical determinant
of long-term survival. This study validates a previously reported preoperative clinical T …

Futibatinib is a novel irreversible FGFR 1–4 inhibitor that shows selective antitumor activity against FGFR-deregulated tumors

…, S Otsuki, K Funabashi, M Yashiro, K Matsuo… - Cancer Research, 2020 - AACR
Preclinical characterization of futibatinib, an irreversible FGFR1–4 inhibitor, demonstrates
selective and potent antitumor activity against FGFR-deregulated cancer cell lines and …

Hilar cholangiocarcinoma: the memorial sloan-kettering cancer center experience

FG Rocha, K Matsuo, LH Blumgart… - Journal of hepato-biliary …, 2010 - Springer
Background/purpose Hilar cholangiocarcinoma (HCCA) is a rare cancer with a low
resectability rate, frequent recurrence after resection and an overall poor outcome. It is widely …

Anatomic versus limited nonanatomic resection for solitary hepatocellular carcinoma

K Tanaka, H Shimada, C Matsumoto, K Matsuo… - Surgery, 2008 - Elsevier
BACKGROUND: Although anatomic liver resection is preferred when treating hepatocellular
carcinoma (HCC), evidence that it improves survival when compared with an adequate …

[HTML][HTML] Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models

…, H Kazuno, Y Yamada, K Matsuo - Oncology …, 2014 - spandidos-publications.com
TAS-102 is a novel oral nucleoside antitumor agent containing trifluridine (FTD) and tipiracil
hydrochloride (TPI). The compound improves overall survival of colorectal cancer (CRC) …

Histologic features after surgery associating liver partition and portal vein ligation for staged hepatectomy versus those after hepatectomy with portal vein embolization

K Matsuo, T Murakami, D Kawaguchi, Y Hiroshima… - Surgery, 2016 - Elsevier
Objective We compared histologic findings in nonneoplastic portions of liver resected
during surgery associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) …

Importance of complete pathologic response to prehepatectomy chemotherapy in treating colorectal cancer metastases

K Tanaka, H Takakura, K Takeda, K Matsuo… - Annals of …, 2009 - journals.lww.com
Objective: We studied the influence of complete pathologic response of colorectal cancer
liver metastases to prehepatectomy chemotherapy on long-term survival after hepatectomy. …

Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries

JM Butte, K Matsuo, M Gönen, MI D'Angelica… - Journal of the American …, 2011 - Elsevier
BACKGROUND:: Gallbladder cancer (GBCA) is a rare malignancy with a variable incidence
worldwide. This study analyzed GBCA patients treated at centers in 3 countries. The aim …

Relationship between intraoperative fluid administration and perioperative outcome after pancreaticoduodenectomy: results of a prospective randomized trial of acute …

M Fischer, K Matsuo, M Gonen, F Grant, RP DeMatteo… - 2010 - journals.lww.com
Background: Pancreaticoduodenectomy (PD) can be associated with significant blood loss
and transfusion requirements, with potential adverse short-and long-term consequences. The …